MetaADEDB 2.0 @ LMMD
Gadobenic acid
(MXZROTBGJUUXID-UHFFFAOYSA-K)
Structure
SMILES
[O-]C(=O)CN(C(C(=O)[O-])COCc1ccccc1)CCN(CC(=O)[O-])CCN(CC(=O)[O-])CC(=O)[O-].[Gd+3].[H+].[H+]
Type(s)
Approved; Investigational
ATC code(s)
V08CA08
Molecular Formula:
C22H26GdN3O11
Molecular Weight:
667.721
Log P:
-7.7727
Hydrogen Bond Acceptor:
14
Hydrogen Bond Donor:
0
TPSA:
219.6
CAS Number(s):
113662-23-0
Synonym(s)
1.
Gadobenic acid
2.
2-[2-[Carboxylatomethyl(carboxymethyl)amino]ethyl-[2-[carboxylatomethyl-(1-carboxy-2-phenylmethoxyethyl)amino]ethyl]amino]acetate;gadolinium(3+)
3.
2-[2-[2-[Bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]-3-phenylmethoxypropanoate;gadolinium(3+);hydron
4.
Gadobenate
5.
2-[2-[2-[Bis(carboxylatomethyl)amino]ethyl-(carboxymethyl)amino]ethyl-(carboxymethyl)amino]-3-phenylmethoxypropanoate;gadolinium(3+)
6.
Gadobenat
External Link(s)
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Contrast media reactionFAERS: 3US FAERS
2NauseaFAERS: 3SIDER
US FAERS
3PruritusFAERS: 3SIDER
US FAERS
4UrticariaFAERS: 3SIDER
US FAERS
5Unresponsive to stimuliFAERS: 2US FAERS
6Acute myocardial infarctionFAERS: 1US FAERS
7AngioedemaFAERS: 1SIDER
US FAERS
8Cardiac ArrestFAERS: 1SIDER
US FAERS
9Chest discomfortFAERS: 1US FAERS
10ChokingFAERS: 1US FAERS
11DizzinessFAERS: 1SIDER
US FAERS
12Epigastric discomfortFAERS: 1US FAERS
13ErythemaFAERS: 1SIDER
US FAERS
14Feeling abnormalFAERS: 1SIDER
US FAERS
15FlushingFAERS: 1SIDER
US FAERS
16HypotensionFAERS: 1SIDER
US FAERS
17MalaiseFAERS: 1SIDER
US FAERS
18Muscle RigidityFAERS: 1US FAERS
19MyalgiaFAERS: 1SIDER
US FAERS
20Oral pruritusFAERS: 1US FAERS
21PallorFAERS: 1US FAERS
22Respiratory DepressionFAERS: 1US FAERS
23Respiratory distressFAERS: 1US FAERS
24SomnolenceFAERS: 1SIDER
US FAERS
25SyncopeFAERS: 1SIDER
US FAERS
26Throat irritationFAERS: 1US FAERS
27VomitingFAERS: 1SIDER
US FAERS
28Abdominal PainSIDER
29Abdominal discomfortSIDER
30Abnormal visionSIDER
31Alanine Aminotransferase IncreasedSIDER
32AlbuminuriaSIDER
33Anaphylactic shockSIDER
34Anaphylactoid ReactionSIDER
35AnxietySIDER
36AphasiaSIDER
37ArthralgiaSIDER
38Aspartate Aminotransferase IncreasedSIDER
39AstheniaSIDER
40AsthmaSIDER
41Atrial FibrillationSIDER
42Back PainSIDER
43BasophiliaSIDER
44Blood albumin decreasedSIDER
45Blood albumin increasedSIDER
46Blood alkaline phosphatase increasedSIDER
47Blood and lymphatic system disordersSIDER
48Blood chloride decreasedSIDER
49Blood creatinine increasedSIDER
50Blood glucose increasedSIDER
51Blood iron increasedSIDER
52Blood lactate dehydrogenase increasedSIDER
53Blood urea increasedSIDER
54Blood urine presentSIDER
55BradycardiaSIDER
56BronchitisSIDER
57BronchospasmSIDER
58Burning sensationSIDER
59Chest PainSIDER
60ChillsSIDER
61Circumoral paresthesiaSIDER
62ConjunctivitisSIDER
63ConstipationSIDER
64Cramps of lower extremitiesSIDER
65Creatinine increasedSIDER
66CyanosisSIDER
67DeafnessSIDER
68Deep Vein ThrombosisSIDER
69Depressed Level of ConsciousnessSIDER
70DermatitisSIDER
71DiscomfortSIDER
72DysgeusiaSIDER
73DyspepsiaSIDER
74Ear and labyrinth disordersSIDER
75EcchymosisSIDER
76Electrocardiogram abnormalSIDER
77Electrocardiogram changeSIDER
78EmbolismSIDER
79EnteritisSIDER
80ExtravasationSIDER
81Eye painSIDER
82FatigueSIDER
83Feeling ColdSIDER
84Gamma-Glutamyltransferase IncreasedSIDER
85Gastrointestinal PainSIDER
86GlycosuriaSIDER
87HeadacheSIDER
88HemiplegiaSIDER
89Hepatic impairmentSIDER
90HypersensitivitySIDER
91HyperventilationSIDER
92InfectionSIDER
93InfestationSIDER
94InflammationSIDER
95Injection Site ReactionSIDER
96Injection site burningSIDER
97Injection site erythemaSIDER
98Injection site extravasationSIDER
99Injection site inflammationSIDER
100Injection site painSIDER
101Injection site vesiclesSIDER
102Injection site warmthSIDER
103Joint sprainSIDER
104Lactic dehydrogenase activity increasedSIDER
105LaryngospasmSIDER
106LeukocytosisSIDER
107LeukopeniaSIDER
108Lymphocyte count increasedSIDER
109MalnutritionSIDER
110Monocyte count increasedSIDER
111MonocytosisSIDER
112Musculoskeletal discomfortSIDER
113MyositisSIDER
114NasopharyngitisSIDER
115Night sweatsSIDER
116PainSIDER
117PalpitationsSIDER
118PhlebitisSIDER
119Protein urine presentSIDER
120ProteinuriaSIDER
121Pulmonary EmbolismSIDER
122Pulmonary congestionSIDER
123RalesSIDER
124Rash erythematousSIDER
125Respiratory FailureSIDER
126Respiratory tract congestionSIDER
127RhinitisSIDER
128ShockSIDER
129Sinus bradycardiaSIDER
130StuporSIDER
131SweatingSIDER
132SwellingSIDER
133TachycardiaSIDER
134ThirstSIDER
135ThrombocytosisSIDER
136TinnitusSIDER
137TonsillitisSIDER
138TremorSIDER
139Urinary IncontinenceSIDER
140Urinary tract infectionSIDER
141Urticaria localisedSIDER
142Vasodilation procedureSIDER
143VasodilationSIDER
144Ventricular arrhythmiaSIDER
145Visual ImpairmentSIDER
146WheezingSIDER
147White blood cell count decreasedSIDER
148nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.